Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft

被引：34
作者：
Alachkar, Nada [1 ]
Bagnasco, Serena M. [2 ]
Montgomery, Robert A. [3 ]
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA
来源：
TRANSPLANT INTERNATIONAL | 2012年 / 25卷 / 08期
关键词：
MUTATIONS;
D O I：
10.1111/j.1432-2277.2012.01497.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：e93 / e95
页数：3
相关论文
共 9 条
[1]   Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) thrombocytic thrombopenic purpura (TTP) [J].
Benz, Kerstin ;
Amann, Kerstin .
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (02) :265-270
[2]   Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance-of genetic background [J].
Bresin, Elena ;
Daina, Erica ;
Noris, Marina ;
Castelletti, Federica ;
Stefanov, Rumen ;
Hill, Prudence ;
Goodship, Timothy H. J. ;
Remuzzi, Giuseppe .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01) :88-99
[3]   Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation [J].
Davin, Jean-Claude ;
Gracchi, Valentina ;
Bouts, Antonia ;
Groothoff, Jaap ;
Strain, Lisa ;
Goodship, Tim .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) :708-711
[4]   Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome [J].
Delvaeye, Mieke ;
Noris, Marina ;
De Vriese, Astrid ;
Esmon, Charles T. ;
Esmon, Naomi L. ;
Ferrell, Gary ;
Del-Favero, Jurgen ;
Plaisance, Stephane ;
Claes, Bart ;
Lambrechts, Diether ;
Zoja, Carla ;
Remuzzi, Giuseppe ;
Conway, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04) :345-357
[5]   The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome [J].
Dragon-Durey, M-A ;
Blanc, C. ;
Marliot, F. ;
Loirat, C. ;
Blouin, J. ;
Sautes-Fridman, C. ;
Fridman, W. H. ;
Fremeaux-Bacchi, V. .
JOURNAL OF MEDICAL GENETICS, 2009, 46 (07) :447-450
[6]   Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome [J].
Fremeaux-Bacchi, Veronique ;
Miller, Elizabeth C. ;
Liszewski, M. Kathryn ;
Strain, Lisa ;
Blouin, Jacques ;
Brown, Alison L. ;
Moghal, Nadeem ;
Kaplan, Bernard S. ;
Weiss, Robert A. ;
Lhotta, Karl ;
Kapur, Gaurav ;
Mattoo, Tej ;
Nivet, Hubert ;
Wong, William ;
Gie, Sophie ;
de Ligny, Bruno Hurault ;
Fischbach, Michel ;
Gupta, Ritu ;
Hauhart, Richard ;
Meunier, Vincent ;
Loirat, Chantal ;
Dragon-Durey, Marie-Agnes ;
Fridman, Wolf H. ;
Janssen, Bert J. C. ;
Goodship, Timothy H. J. ;
Atkinson, John P. .
BLOOD, 2008, 112 (13) :4948-4952
[7]   Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome [J].
Nester, Carla ;
Stewart, Zoe ;
Myers, David ;
Jetton, Jennifer ;
Nair, Ramesh ;
Reed, Alan ;
Thomas, Christie ;
Smith, Richard ;
Brophy, Patrick .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06) :1488-1494
[8]   Eculizumab for Atypical Hemolytic-Uremic Syndrome. [J].
Nuernberger, Jens ;
Witzke, Oliver ;
Saez, Anabelle Opazo ;
Vester, Udo ;
Baba, Hideo Andreas ;
Kribben, Andreas ;
Zimmerhackl, Lothar Bernd ;
Janecke, Andreas R. ;
Nagel, Mato ;
Kirschfink, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :542-544
[9]   Prophylactic Eculizumab after Renal Transplantationin Atypical Hemolytic-Uremic Syndrome. [J].
Zimmerhackl, Lothar Bernd ;
Hofer, Johannes ;
Cortina, Gerard ;
Mark, Walter ;
Wuerzner, Reinhard ;
Jungraithmayr, Therese C. ;
Khursigara, Gus ;
Kliche, Kay O. ;
Radauer, Wolfgang .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18) :1746-1748
1